InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: None

Thursday, 01/08/2015 10:36:54 AM

Thursday, January 08, 2015 10:36:54 AM

Post# of 118409
Sounds promising on paper, but this "rapid" development through IND has a non existent track record, no that's incorrect, it has a track record of non production thus far with Koos and RGBP.

Why is it that we have not heard of any development for months on the status of HemaXellerate I and DCellVax progress? Why, if there has been any progress going forward, why wouldn't they want to brag about it? Instead, we are 2 years removed from IND of HemaXellerate with nothing to show but a 2/3rds approval for clinical trials and no update for months whether there is any hope that it will ever take place, since the safe data was lacking and we have no update as to whether any further testing is being performed. DCellVax is over its projected submission for approval, so, in fact, why should we think this N... will be any different.

On the other hand, companies are breaking ground. Just came across JUNO which IPOed at 24 and is now over 50 within days on cell based cancer treatments. The more time passes without positive, concrete news on data and results, the less chance RGBP will ever make it.